The VISTA trial was a randomized, double-blind, placebo-controlled, multi-center study designed to evaluate PIPE-307’s safety and efficacy in RRMS patients. The company continues to analyze data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback